πŸ‡ΊπŸ‡Έ FDA
Patent

US 9352027

Albumin-free factor VIII formulations

granted A61KA61K38/37A61K47/02

Quick answer

US patent 9352027 (Albumin-free factor VIII formulations) held by UNIVERSITY OF CONNECTICUT expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/37, A61K47/02, A61K47/10, A61K47/18